POPULARITY
I've known Jane Mogel since we were freshman in college—50 years!!! And her smart, funny, charming husband, Peter Pitts for almost as long. I went to their wedding in the mid 80's. Jane has a successful business as an interior designer and Peter has a global trotting business as the co-founder of the Center for Medicine in the Public Interest. His research, reporting and public appearances range from the New York Times to The Daily Show with John Stewart. Though I don't usually have close friends on, (I'm trying to be a real shrink, remember?!!), I make an exception here so Jane and I can exchange some college stories and we can talk about Jane and Peter's parenting adventures with their two boys, Jeremy and Ben, now both in their mid-thirties and doing well. Jane would invite me to stay with her family in New York City in the later 70's and her parents were a big influence on me. They were very sophisticated for a young person like me and they opened my mind to a lot of new things. Her father, Len Mogel was the publisher of the National Lampoon in it's heyday, so some fun stories from that time too. I moved to the East Village right after college and Jane had her own place in the city by then, so we had a lot of fun running around NYC in those years too!
There's a new bill that could help many rare disease patients gaining traction, but it still has a long way to go. This week, we're joined by Peter Pitts, a Former FDA Associate Commissioner, who gives us the lowdown on the Promising Pathways Act. He tells us what types of diseases are likely to be affected by this bill, and why it will make a significant difference in the lives of patients. We also speak with Senator Mike Braun of Indiana, who introduced the bill alongside other legislators of both parties. Need help? The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands? Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at the Patients Rising Helpline. Have a question or comment about the show, or want to suggest a show topic or share your story as a patient correspondent? Drop us a line: podcast@patientsrising.org The views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising, nor do the views and opinions stated on this show reflect the opinions of a guest's current or previous employers.
Rich Brennan, Vice President of Federal Affairs for the ALS Association, explains the approval pathway for Tofersen, a new ALS drug, and what that means for patients; Peter Pitts, President and co-founder of the Center for Medicine in the Public Interest, discusses how this FDA review process evaluates rare disease treatments; the House Health subcommittee discusses copay accumulators and PBMs in hearing; patient correspondent Larry Falivena shares his experience living with ALS and calls for more research funding. Rich Brennan- Vice President of Federal Affairs for the ALS Association US FDA panel backs accelerated approval for Biogen's ALS drug Patients Rising Now Letter FDA Advisory Council Peter Pitts- President and co-founder of the Center for Medicine in the Public Interest Health Hearing: “Lowering Unaffordable Costs: Examining Transparency and Competition in Health Care” - (3:15:50) Darla S. Bell- Copay Accumulator Adjustment Programs: Anti-Patient Practice Sarah Page- MS, American v Argentinan health care, and great family support Larry Falivena (Constituent, NC CD-14)
On today's episode, Matthew welcomes Kristie Kuhl (Global Managing Director, Health and Wellness, Zeno Group) and Peter Pitts (Former FDA Associate Commissioner and President of the Center for Medicine in the Public Interest) to share highlights and recap their panel session at the 2022 STAT Summit in Boston, MA.The STAT Summit is a prestigious annual event that welcomes global leaders to discuss healthcare's most critical topics, and Matthew, Peter, and Kristi's panel, "We The Patients," did not disappoint.With a focus on consumerism in healthcare and how direct marketing has the potential to be the new "patient engagement," attendees learned the value of thinking consumer vs. thinking patient. Put on your thinking hat and prepare for a rollicking and highly entertaining discussion.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Afghanistan, one year later. David Loyn, former BBC reporter and author of "The Long War" joins to update on what's happening on the ground in Afghanistan, with the Taliban and the win the Biden Administration has with getting al-Zawahiri. And Lisa Wexler, a lawyer and judge looks at what happened with the Trump raid and what the AG should do. And finally, Peter Pitts joins about how big Pharma is controlled by Chinese manufacturing. Is there a solution?
7/18/22 - Senator Richard Blumenthal And Author Peter Pitts by The Lisa Wexler Show
Lisa discusses the state of the healthcare industry with Peter Pitts. Photo: iStock / Getty Images Plus photobyphotoboy
Rich Valdes fills in for Jim Bohannon. He speaks with: John O'Connor, Trial Lawyer, On to discuss the 50th Anniversary of the Watergate break in. Nicolas Giordano, Host of the P.A.S. Report Podcast, On to discuss the news of the day. Darin Selnick, Senior Advisor of Concerned Veterans for America, On to discuss the Department of Veterans Affairs weighing limiting veterans' access to doctors outside of Veterans Affairs hospitals. Peter Pitts, Former FDA Associate Commissioner, On to discuss COVID vaccines for children under 5. And ... Your thoughts on the latest in the news. See omnystudio.com/listener for privacy information.
When most people think of college, they actually think of large public and private universities or community colleges. But what about all of those tiny, often overlooked gems sprinkled like stars across the firmament of higher education? Amy and Mike invited admissions expert V. Peter Pitts to sing the praises of attending a small college. What are five things you will learn in this episode? What kind of school qualifies as a “small” college? What is different or unique about attending a small college? Do small colleges necessarily offer fewer opportunities than larger schools? What kind of student thrives in a small college environment? How can a student attending a large university create a 'small college' experience? MEET OUR GUEST Peter Pitts recently retired from 42 years in the College Admission profession, most recently with Monmouth College of Illinois. Over his 27 years at Monmouth, he recruited over 2,000 students and still keeps in touch with many of them. He is originally from Iowa, and has an undergraduate degree from Wartburg College (IA) and a Master's Degree from the University of Iowa, both degrees in Sociology. In his retirement, Peter publishes a website–U3K4College.com–that celebrates small private colleges. He also gives presentations to high school classes about a variety of college admission topics. His latest book is Common Sense Guide to Choosing a College---Making a Case for Small Residential Colleges. Peter previously appeared on this podcast in episode 163 to discuss DO COLLEGE MAJORS MATTER? Peter can be reached at vpeterpitts@gmail.com. LINKS In Praise of Smaller Schools RELATED EPISODES ATTENDING A LIBERAL ARTS COLLEGE ATTENDING A WOMEN'S COLLEGE ATTENDING A LARGE PUBLIC UNIVERSITY ABOUT THIS PODCAST Tests and the Rest is THE college admissions industry podcast. Explore all of our episodes on the show page. ABOUT YOUR HOSTS Mike Bergin is the president of Chariot Learning and founder of TestBright. Amy Seeley is the president of Seeley Test Pros. If you're interested in working with Mike and/or Amy for test preparation, training, or consulting, feel free to get in touch through our contact page.
A discussion on scary health issues and corruption took place with special guest, Professor Peter Pitts. Peter Pitts is President and co-founder of the Center for Medicine in the Public Interest, and a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration where of his many tasks. He served as senior communications and policy adviser to the Commissioner. Professor Pitts discussed how parents have been in panic over the baby formula shortage, what caused this shortage, and what the FDA is doing to prevent it from continuing. He also explained why it has taken so long to fix the baby formula shortage, and who is to blame. He went into detail about when it became of knowledge that there was a problem, and also that there was purposeful hiding from the FDA about the manufacturing problems. The other scary issue discussed was security breaches on medical devices. In April of this year the Department of Health and Human Services posted an alert to healthcare agencies of an exceptionallyaggressive ransomware group targeting hospitals and healthcare facilities. There can actually be an unauthorized person or persons who will attack and take full control of system access, remote code execution, change configuration, file system read accession, log information access, and also denial of service. We are NOT prepared for this. Not all medical facilities are prepared for this. Another issue discussed was that WTO World Trade Organization has been trying to stop the stealing of Covid 19 vaccinepatents, and about the monkeypox vaccine that is really the smallpox vaccine, and how health has really turned into a business. Dr. Pitts recently published his new book, The Next Normal on how we can apply the lessons learned from COVID-19 to advance other areas of healthcare.
A discussion on scary health issues and corruption took place with special guest, Professor Peter Pitts. Peter Pitts is President and co-founder of the Center for Medicine in the Public Interest, and a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration where of his many tasks. He served as senior communications and policy adviser to the Commissioner. Professor Pitts discussed how parents have been in panic over the baby formula shortage, what caused this shortage, and what the FDA is doing to prevent it from continuing. He also explained why it has taken so long to fix the baby formula shortage, and who is to blame. He went into detail about when it became of knowledge that there was a problem, and also that there was purposeful hiding from the FDA about the manufacturing problems. The other scary issue discussed was security breaches on medical devices. In April of this year the Department of Health and Human Services posted an alert to healthcare agencies of an exceptionallyaggressive ransomware group targeting hospitals and healthcare facilities. There can actually be an unauthorized person or persons who will attack and take full control of system access, remote code execution, change configuration, file system read accession, log information access, and also denial of service. We are NOT prepared for this. Not all medical facilities are prepared for this. Another issue discussed was that WTO World Trade Organization has been trying to stop the stealing of Covid 19 vaccinepatents, and about the monkeypox vaccine that is really the smallpox vaccine, and how health has really turned into a business. Dr. Pitts recently published his new book, The Next Normal on how we can apply the lessons learned from COVID-19 to advance other areas of healthcare.
The Biden administration airlifts over a million baby formula bottles from Europe as it struggles to fill a nationwide shortage, amid a growing political and public health crisis and calls to address the systemic issues that caused the shortage in the first place. Guests: TiffanyAnn Goodson: Working Mother and Member of Mocha Moms; Peter Pitts, Former Associate Commissioner of the US Food and Drug Administration; JD Scholten, Senior Adviser to American Economic Liberties Project
In the third hour of the morning show, Larry O'Connor and Mary Katharine Ham talked to former FDA Associate Commissioner Peter Pitts and Julio Rosas. They also talked about a senior year prank in Montana, Johnny Depp trial highlights and Mattel making a trans Barbie. For more coverage on the issues that matter to you, visit www.WMAL.com, download the WMAL app or tune in live on WMAL-FM 105.9 FM from 5-9 AM ET. To join the conversation, check us out on Twitter: @WMALDC, @LarryOConnor, @Jgunlock,and @patrickpinkfile. Show website: https://www.wmal.com/oconnor-company/ See omnystudio.com/listener for privacy information.
Peter Pitts, former FDA Associate Commissioner, currently the President and co-founder of the Center for Medicine in the Public Interest and erves as a Visiting Professor at the University of Paris School of Medicine, joined WMAL's "O'Connor and Company" radio program on Thursday about the baby formula shortage. F.D.A. Chief Details ‘Shocking' Conditions at Baby Formula Plant FDA chief says covid, mail room failures hindered formula response For more coverage on the issues that matter to you, visit www.WMAL.com, download the WMAL app or tune in live on WMAL-FM 105.9 FM from 5-9 AM ET. To join the conversation, check us out on Twitter: @WMALDC, @LarryOConnor, @Jgunlock,and @patrickpinkfile. Show website: https://www.wmal.com/oconnor-company/ See omnystudio.com/listener for privacy information.
The U.S. Food and Drug Administration recently announced it has proposed product standards to prohibit menthol cigarettes and prohibit all characterizing flavors (other than tobacco) in cigars.These actions have the potential to significantly reduce disease and death from combusted tobacco product use, the leading cause of preventable death in the U.S., by reducing youth experimentation and addiction and increasing the number of smokers that quit.Peter Pitts is President and co-founder of the Center for Medicine in the Public Interest. He also serves as a Visiting Professor at the University of Paris School of Medicine and was a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration where he served as senior communications and policy adviser to the Commissioner. He sits down with Dr. Roizen to talk about the dangers of flavored cigarettes and why this is such an important step in the fight against cigarette addiction.
The FDA is working to ban menthol cigarettes. The U.S. Food and Drug Administration recently announced it has proposed product standards to prohibit menthol cigarettes and prohibit all characterizing flavors (other than tobacco) in cigars.These actions have the potential to significantly reduce disease and death from combusted tobacco product use, the leading cause of preventable death in the U.S., by reducing youth experimentation and addiction and increasing the number of smokers that quit.Peter Pitts is President and co-founder of the Center for Medicine in the Public Interest. He also serves as a Visiting Professor at the University of Paris School of Medicine and was a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration where he served as senior communications and policy adviser to the Commissioner. He sits down with Dr. Roizen to talk about the dangers of flavored cigarettes and why this is such an important step in the fight against cigarette addiction.
The FDA is working to ban menthol cigarettes. The U.S. Food and Drug Administration recently announced it has proposed product standards to prohibit menthol cigarettes and prohibit all characterizing flavors (other than tobacco) in cigars.These actions have the potential to significantly reduce disease and death from combusted tobacco product use, the leading cause of preventable death in the U.S., by reducing youth experimentation and addiction and increasing the number of smokers that quit.Peter Pitts is President and co-founder of the Center for Medicine in the Public Interest. He also serves as a Visiting Professor at the University of Paris School of Medicine and was a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration where he served as senior communications and policy adviser to the Commissioner. He sits down with Dr. Roizen to talk about the dangers of flavored cigarettes and why this is such an important step in the fight against cigarette addiction.
Prof. Peter Pitts, Former FDA Associate Commissioner, President & co-founder of the Center for Medicine in the Public Interest, and a Visiting Professor at the University of Paris School of Medicine Hilary Kramer, One of Wall Street's most successful equity analysts & investment managers See omnystudio.com/listener for privacy information.
Ken is joined by Peter Pitts, Former Associate Commissioner of the FDA See omnystudio.com/listener for privacy information.
HOUR 1T and T talk weekend and summer airline travel prices going up while stocks are going downU.S. solar industry is in turmoil because solar panel manufacturer in San Jose, Auxin Solar, asked the Commerce Dept. to launch an investigation into whether Chinese solar products were being illegally funneled through other Asian countries on their way to the US / (MB) https://www.morningbrew.com/daily/stories/2022/05/08/us-solar-industry-in-state-of-chaos-during-tariff-probe?Tibetan climber breaks world record / (NPR) https://www.npr.org/2022/05/08/1097485283/nepali-climber-climbed-everest-for-the-26th-time-world-recordElon Musk makes a cryptic tweet about his dying Willow Alaska vehicle wreck on Parks Hwy closes both directions / (ADN) https://www.adn.com/alaska-news/mat-su/2022/05/09/collision-closes-parks-highway-near-willow/Peter Pitts, former FDA Associate Commissioner, joins Tom to discuss the ban on menthol cigarettes(MB) Ukraine latest: First Lady Jill Biden made a surprise visit to Ukraine on Mother's Day and met with Ukrainian First Lady Olena Zelenska. It was the first public appearance by Zelenska since Russia's invasion on Feb. 24. On the war front, a Russian strike killed around 60 people after flattening a school they were sheltering in the basement of, Ukrainian President Volodymyr Zelensky said.Dr. Strange's second movie release breaks records / (Variety) https://variety.com/2022/film/news/doctor-strange-2-box-office-opening-weekend-disney-marvel-cinematic-universe-1235261390/HOUR 2Chugach Electric's new CEO sues after being let go under the probationary 3-month period / (ADN) https://www.adn.com/business-economy/2022/05/08/court-battle-brewing-over-firing-of-chugach-electric-ceo/Alaska's first supercharger station opens on the Kenai Peninsula for Tesla's and electric cars / (ANS) https://www.alaskasnewssource.com/2022/05/07/alaskas-first-tesla-supercharger-station-opens-soldotna/Tom A overviews his show's sponsors and praises Dr. Larry Lawson, MD at Midnight Sun OncologyTom and Tom discuss eating Rick Whitbeck if in a survival situation and he passed firstTom and Tom talk about the movies "Awake" and "Alive" and "Bucket List" and where they'd travel for their own bucket list
Today on the Jimmy Barrett Show: Jimmy discusses the Johnny Depp trial Dr. Peter Pitts former FDA Commissioner on the new Covid varient Dr. Mark Sherwood on vitamins
Hour 3: Former FDA Associate Commissioner, Peter Pitts joins Mark Reardon to discuss the federal judge striking down the mask mandate for mass transit. Then, Manhattan Institute Scholar and author of "The War on Cops", Heather Mac Donald joins the Mark Reardon Show to discuss her latest piece headlined, "When 'white' becomes an epithet: Conservatives must rebut the equation between whiteness and evil."
Peter Pitts is a former Associate Commissioner of the FDA, current President of the Center for Medicine in the Public Interest. *Follow him on Twitter: @PeterPitts
Today, Rich reacts to the Smackdown at the Oscar Awards. Then, Trump announces lawsuit against Hillary Clinton. Plus, former FDA Associate Commissioner. Prof. Peter Pitts calls in to discuss the Shanghai lockdown. Portions of today's program are brought to you by JustFacts.com/Rich. Comment and follow on Facebook, Twitter, GETTR, and Parler or visit us at RichValdes.com.
Prof. Peter Pitts talks about the pharmaceutical companies asking for authorization for a second booster shot.
Guests: Doug Bandow, Senior Fellow at the Cato Institute, On to discuss the long term consequences of Russia's invasion of Ukraine. Peter Pitts, Former Associate Commissioner of the FDA, On to discuss if it will be necessary to get a fourth COVID booster shot. And ... Your thoughts on the latest in the news. See omnystudio.com/listener for privacy information.
Former FDA Associate Commissioner Professor Peter Pitts discusses whether we really should still be wearing masks.
Now that Dr. Robert Califf has been sworn in as permanent FDA chief, he'll confront a host of pandemic policy and other challenges. We asked Peter Pitts, a former FDA associate commissioner, to weigh in as Califf begins his second stint in the agency's top job.
Peter Pitts, author of “The Next Normal” talks to Brian about the latest COVID-related news of the day, a new HIV variant discovered, and more.
Former FDA Associate Commissioner for External Relations Peter Pitts, comes on the show to talk about vaccines, masks, and should you get your 5 year old vaccinated... @mikeragu https://cmpi.org/
Featuring Former FDA Associate Commissioner Peter Pitts On Blue States Mask Mandates by Kevin McCullough Radio
Inez Stepman from the IWF takes aim at the ridiculous notion that Governor Kathy Hochul continues to extend the mask mandate on all kids in public school throughout the entire state and what a depressing toll this pandemic has taken on everybody. Former Food & Drug Associate Commissioner, Peter Pitts, talks about the lack of science used by the Governing body of New York that continues to adhere to these mask mandates while every other blue state begins to phase out the masks in schools. Author Max Lucado gives us another update about his 3:16 Bible Study course currently ongoing through his website. Jane Anne Banyra looks at visualizing our goals and what is to be done to get into a force of habit.
Amid industry's ongoing drive to speed drug discovery, clinical development and commercial success, government regulation can sometimes seem slow moving. But even a quick look at regulatory highlights from 2021 shows nothing could be further from the truth. From COVID-19 and cancer to Aduhelm and the broader health care ecosystem, so much has changed – and not just in the U.S. Join us for perspective on this fast-changing landscape from Peter Pitts, president of the Center for Medicine in the Public Interest, among other roles. “All of a sudden, everybody is a regulatory expert,” he said. Will free beer get us where we need to go? Listen to find out. See acast.com/privacy for privacy and opt-out information.
Peter Pitts is a former Associate Commissioner of the FDA, current President of the Center for Medicine in the Public Interest *Follow him on Twitter: @PeterPitts.
13 U.S. service members were killed in a terror attack at the Kabul airport on Thursday by a suicide bomber. It was the single largest loss of life for U.S. forces in Afghanistan in more than a decade. President Biden on Thursday vowed to retaliate against the terrorists involved in killing U.S. soldiers. The evacuation out of Afghanistan continues as August 31st gets closer for the U.S. to full withdrawal from the country. Jared speaks with FOX News Pentagon Reporter Lucas Tomlinson, who has been covering the withdrawal and evacuations out of Afghanistan since the beginning about this week's deadly attack and the President's response. Earlier this week the Food and Drug Administration granted full approval to Pfizer's COVID-19 vaccine for individuals 16 years and older. While coronavirus vaccines developed by Pfizer, Moderna, and Johnson & Johnson have all previously been granted emergency use authorization (EUA), the FDA's full approval of the Pfizer vaccine is a huge milestone, especially for those Americans who were vaccine-hesitant and contributing to low vaccination rates in the U.S. Jared speaks with former Food and Drug Administration associate commissioner, Peter Pitts about why it's important if he thinks Moderna and Johnson and Johnson will get full FDA approval and if he thinks this will help those who are vaccine-hesitant finally get vaccinated against the virus.
13 U.S. service members were killed in a terror attack at the Kabul airport on Thursday by a suicide bomber. It was the single largest loss of life for U.S. forces in Afghanistan in more than a decade. President Biden on Thursday vowed to retaliate against the terrorists involved in killing U.S. soldiers. The evacuation out of Afghanistan continues as August 31st gets closer for the U.S. to full withdrawal from the country. Jared speaks with FOX News Pentagon Reporter Lucas Tomlinson, who has been covering the withdrawal and evacuations out of Afghanistan since the beginning about this week's deadly attack and the President's response. Earlier this week the Food and Drug Administration granted full approval to Pfizer's COVID-19 vaccine for individuals 16 years and older. While coronavirus vaccines developed by Pfizer, Moderna, and Johnson & Johnson have all previously been granted emergency use authorization (EUA), the FDA's full approval of the Pfizer vaccine is a huge milestone, especially for those Americans who were vaccine-hesitant and contributing to low vaccination rates in the U.S. Jared speaks with former Food and Drug Administration associate commissioner, Peter Pitts about why it's important if he thinks Moderna and Johnson and Johnson will get full FDA approval and if he thinks this will help those who are vaccine-hesitant finally get vaccinated against the virus.
Peter Pitts is a former Associate Commissioner of the FDA, current President of the Center for Medicine in the Public Interest. *Follow him on Twitter: @PeterPitts. why are vaccines still only “emergency use”?
Drama continues to unfold following the FDA's controversial approval of a new Alzhiemer's treatment. Members of the FDA's advisory committee voted against approval, and some members resigned in protest. But how does this impact you or loved ones with chronic disease? On this episode: Peter Pitts, a former FDA Associate Commissioner, who previously oversaw the committee process. He explains how the committees make recommendations on new and emerging treatments and drugs for rare and chronic diseases. And how reforms to strict conflict of interest rules could bring more patient voices to the table. Plus, Field Correspondent Kate Pecora speaks with lung cancer survivor Jeff Julian on overcoming the odds and his search to find the best treatment for him. Hosts:Terry Wilcox, Executive Director, Patients RisingDr. Robert Goldberg, “Dr. Bob,” Co-Founder and Vice President of the Center for Medicine in the Public InterestKate Pecora, Field Correspondent, Patients RisingGuests:Peter Pitts, President and Co-Founder, Center for Medicine in the Public InterestJeff Julian, Cancer AdvocateJody Quinn, Patient CorrespondentLinks:3 Experts Have Resigned from an FDA Committee Over Alzheimer's Drug Approval Obamacare survives after Supreme Court rejects latest Republican challengePfizer CEO urges Biden to form coalition to cut drug costsNeed help?The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands? Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.orgHave a question or comment about the show, or want to suggest a show topic or share your story as a patient correspondent?Drop us a line: podcast@patientsrising.orgThe views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.
President Biden says it's time to end American's longest war and bring our troops home from Afghanistan. He has set a withdrawal date for September 11th, which will be the 20th Anniversary of the terrorist attack that send our troops to Afghanistan in the first place. More than 2300 U.S. troops have been killed while deployed there with 3500 troops remaining now. General Jack Keane, a retired 4 star general, chairman of the Institute for the Study of War and FOX NEWS Senior Strategic Analyst, discusses President Biden's decision to withdraw from Afghanistan, President Trump declaring he wanted U.S. troops out of Afghanistan by May 1st and what the impact will be if the U.S. has no physical presence in Afghanistan. The FDA and CDC recommended a pause in the distribution of the Johnson & Johnson Covid-19 vaccine this week. This comes after reports of six women who received the shot getting severe blood clots out of the almost 7-million Johnson and Johnson vaccinations. FOX News Medical contributor Dr. Marc Siegel and former FDA Associate Commissioner, Peter Pitts weigh in on the decision to pause the vaccine, what the process entails and how to curtail "vaccine hesitancy" in light of the news. Plus, commentary by Dr. Robert Jeffress, Fox News contributor and pastor of the Dallas First Baptist Church.
The COVID-19 pandemic has served as a wake-up call for the healthcare ecosystem to recognize the urgencies of working together to achieve life-changing, economy-saving advancements. Leslie Isenegger interview Center for Medicine in the Public Interest President Peter Pitts about his new book, The Value Equation: A Journey Through the Innovation Ecosystem in the Time of COVID, in which he talks about the importance of failing fast, the evolving—and essential—patient voice, and why looking for health care “good guys and bad guys” slows innovation for all.
Almost every conversation about college admissions and choice eventually turns to major. Should teenagers even be expected to know what they want to study for the next four to six years? Amy and Mike invited admissions expert V. Peter Pitts to consider if and when college majors matter. What are five things you will learn in this episode? Should students know what they want to major in when applying to schools? In which cases do majors not matter? Are there examples of majors that are essential for certain career goals? What should inform a student's course of study? What is a better question to ask than, "What do you plan to major in?" MEET OUR GUEST Peter Pitts recently retired from 42 years in the College Admission profession, most recently with Monmouth College of Illinois. Over his 27 years at Monmouth, he recruited over 2,000 students and still keeps in touch with many of them. He is originally from Iowa, and has an undergraduate degree from Wartburg College (IA) and a Master’s Degree from the University of Iowa, both degrees in Sociology. In his retirement, Peter publishes a website--U3K4College.com--that celebrates small private colleges. He also gives presentations to high school classes about a variety of college admission topics. Peter can be reached at vpeterpitts@gmail.com. LINKS Why Majors Do Not Matter RELATED EPISODES COLLEGE DECLASSIFIED: WHAT HIGH SCHOOLERS SHOULD KNOW ABOUT THE NEXT LEVEL PATHWAY PLANNING FOR HIGH SCHOOLERS WHAT EVERY PRE-MED MAJOR SHOULD KNOW ABOUT THIS PODCAST Tests and the Rest is THE college admissions industry podcast. Explore all of our episodes on the show page.
See omnystudio.com/listener for privacy information.
Peter Pitts is a former Associate Commissioner of the FDA, current President of the Center for Medicine in the Public Interest. *Follow him on Twitter: @PeterPitts
See omnystudio.com/listener for privacy information.
Pfizer's Covid-19 “game changing” success. Here's why and when we can expect a vaccine. Also, is a mask mandate coming?
See omnystudio.com/listener for privacy information.
President Trump has simultaneously talked down the power of Covid-19 while trying to push up the release date for a vaccine against the coronavirus. This dissonance has turned many Americans against taking a vaccine once one is developed. Peter Pitts of the Center for Medicine in the Public Interest says for a vaccine to sharply reduce infections of Covid-19, 60% or more of Americans must take it. Anything less, he says, could mean big trouble.
See omnystudio.com/listener for privacy information.
Guests: Dr. Roslyn Layton, Visiting Researcher at Aalborg University Center for Communication, Media, and Information Technology, On to discuss banning Tik Tok in the United States. Jonathan Bydlak, Director of the Fiscal and Budget Policy Project at the R Street Institute, On to discuss banning Tik Tok. Peter Pitts, Former FDA Associate Commissioner, On to discuss the race to find a COVID-19 vaccine. And ... Your thoughts on the ongoing pandemic. See omnystudio.com/listener for privacy information.
Professor Peter Pitts discusses the current status of COVID-19 Vaccines
Peter J. Pitts, a former FDA associate commissioner, is president of the Center for Medicine in the Public Interest and a visiting professor at the University of Paris, Descartes Medical School. See omnystudio.com/policies/listener for privacy information.
Prof. Peter Pitts - Former FDA Associate Commissioner, President and co-Founder, Center for Medicine in the Public Interest, an independent body for the study of health matters
Peter Pitts is a former Associate Commissioner of the FDA, current President of the Center for Medicine in the Public Interest. *Follow him on Twitter: @PeterPitts
Former FDA Commissioner, Peter Pitts is President and co-founder of the Center for Medicine in the Public Interest. Prior to founding CMPI, Pitts was a Senior Fellow for healthcare studies at the Pacific Research Institute. From 2002-2004 Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He supervised FDA's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management. He served on the agency’s obesity working group and counterfeit drug taskforce. His book, Become Strategic or Die, is widely recognized as a cutting edge study of how leadership, in order to be successful over the long term, must be combined with strategic vision and ethical practice. He is the editor of the new book, Coincidence or Crisis, a discussion of global prescription medicine counterfeiting. He has served as an adjunct professor at Indiana University’s School of Public and Environmental Affairs and Butler University. Mr. Pitts also currently serves as a Visiting Professor at University of Paris School of Medicine. You can connect with Peter Pitts everywhere on your favorite social platform. When we touch a heart we change a lifeWhen we change a life we become unstoppable Together! YOU are the BRAND She was cleaning houses before filling houses, your host Connie Pheiff is a Philanthropist, Social Venture Entrepreneur, and #BeyondMeToo Activist is the Jewel in the Crown of the Pheiff Group, Inc. With her distinctive voice audiences everywhere know her. She is blessed from her work as a corporate CEO, award-winning speaker, Podcaster, Mentor, Coach and author. She is provocative, edgy, and brings a genuine humor to the platform. Connie is best known as the Unstoppable DIVA, former executive turned Media Industrialist. In addition to producing the Connie Pheiff Show, she is a serial-entrepreneur, author, speaker, and mentor with her most daring venture leading Talent Concierge, an artist agency with heart. Each week she brings you confident conversations with today's most daring thought-leaders who made the bold choice to go from moving up to moving out and building a successful lifestyle business. The Connie Pheiff Show is heard in 610 countries and tracking nearly 6M impressions each month. And she is not done yet… The Connie Pheiff Show can be heard on… Be sure to subscribe, because you don’t want to miss any of the good stuff. Networks | Benchmarks Apple Radio iHeartRadio Google Radio Stitcher 190 Digital (online) Networks Countries: User reported from 210 countries 6M Podcast Impressions per month BROADCAST YOUR STORY EVERYWHERE Let us know what you need to hear on a future episode of the Connie Pheiff Show. We work with the World’s Most Daring Minds who are keeping the passion of life activated. Apply to be a guest on the Connie Pheiff Show and be certain to subscribe to the show to receive each episode right in your inbox on Have a successful career and ready to share your story with the world but not quite certain how to make it happen? Talent Concierge can help and is now accepting new Talent for 2020. Contact the team at https://talentconcierge.co/contact/ to book the next five-star Talent for your next event Learn more about your ad choices. Visit megaphone.fm/adchoices
Discussing new revolutionary meds to fight Covid-19.
Discussing HERD IMMUNITY, MEDICINES/VACCINE, HOME TESTING and much more...
Countries and U.S. states planning to reopen amid health warnings. Georgia is going to reopen some businesses as early as this week. FDA authorizes first at-home coronavirus test. Chargers unveil their new uniforms for the upcoming season. Tom Brady was thrown out of a closed park in Tampa by a recreation worker. Tasty Tuesday. Former FDA, Peter Pitts, on testing and treatments on coronavirus. Whats Happening. #Smallbusinessshoutout with Leo and Lilly in Woodland Hills. Swamp Watch. LA County Update.
Former FDA Associate Commissioner Peter Pitts and co-founder of the Center for Medicine in the Public Interest on The Scott Sands Show.
discussing SANITIZING, HYGIENE, STAYING SAFE AND BEING SMART - related to COVID - 19.
Some experts say the USA won't return to normalcy until after a Covid-19 vaccine is ready. This former FDA associate commissioner says it may be developed sooner than you think.
Join this powerfully timely and informative Aging GreatFULLy special commercial-free episode as we get answers to the questions you have about "COexisting with COvid-19 COronavirus." Welcoming Former FDA Associate Commissioner and President and co-founder of the Center for Medicine in the Public Interest, Peter Pitts, we will gain more insight on the present state of circumstances, including what society may look like in the months and even years ahead as a result of this worldwide pandemic.Pitts has been a sought-after expert appearing on FOX News, CNBC and many more, and now he brings his commentary and expertise to the Aging GreatFULLy show!Peter Pitts is named one of the 300 “most powerful people in American healthcare,” by Modern Healthcare Magazine and author of Common Sense Healthcare Policy for Common Sense Americans (and Presidential Candidates) Cognito Press, 2019.Tune in for answers to questions you the listeners submitted and discover what hope is on the horizon as we collectively face this unprecedented era of COVID-19. Pitts will talk about the drugs that may help fight COVID-19 such as Hydroxychloroquine, including the development status of a vaccine. Learn what measures we must continue practicing to ensure the ultimate health and well-being of ourselves and others and what the road to Coronavirus resilience and recovery looks like.We want the world to regain and ignite faith in unifying again and we will talk about how and when we may do so, presenting a "new normal" bight, healthy and happy future ahead for all of us.
Former FDA Associate Commissioner Peter Pitts joins to discuss coronavirus drug updates. 3-26-2020 Pat Miller Program
Peter Pitts is a former Associate Commissioner of the FDA, current President of the Center for Medicine in the Public Interest. *Follow him on Twitter: @PeterPitts
Day 12 inside the CQB: Yes!, the coronavirus is taking a hold on all the news, but earthquakes are still happening and most of them are in Puerto Rico. Florida man gets caught stealing toilet paper from a hotel in Orlando. Fmr FDA Assoc. Commissioner Peter Pitts joins the show to talk about the coronavirus and how can we help defeat COVID-19. Kris Cruz has a BIG ANNOUNCEMENT and it involves the coronababy. How are you time managing your time while being quarantine? Subscribe on YouTube Learn more about your ad choices. Visit megaphone.fm/adchoices
Peter Pitts, Author and President of the Center for Medicine in the Public Interest talks, "Common Sense Health Care".
Peter Pitts, Author and President of the Center for Medicine in the Public Interest talks, "Common Sense Health Care".
Peter Pitts, Author and President of the Center for Medicine in the Public Interest talks, "Common Sense Health Care".
Special guests: Peter Pitts & Gunnery Sgt. Jessie Jane Duff. --- Support this podcast: https://anchor.fm/loving-liberty/support
Uncle Milty and Peter Pitts from the Center for Medicine in the Public Interest. --- Support this podcast: https://anchor.fm/loving-liberty/support
190909 - Why Are Dems Counting On Medicare For All? | PETER PITTS by Blanquita Cullum
Update about new locations for weekend commencement activities. … Meet Yulissa Avila and Elizabeth Smith, first graduates of the Peace Corps Prep program. … Retiring Monmouth admission counselor Peter Pitts looks back on a remarkable 42-year career. … Sports Information Director Dan Nolan previews Midwest Conference championships in baseball and track & field. @MCFightingScots @WackerleCenter @MCScotsBaseball @ScotsTFXC
President, Center for Medicine in the Public Interest, and Former FDA Associate Commissioner, Peter Pitts joins John Howell to discuss the measles outbreak that has infected 695 people.
Peter Pitts is President and co-founder of the Center for Medicine in the Public Interest, Prior to founding CMPI, Pitts was a Senior Fellow for healthcare studies at the Pacific Research Institute. From 2002-2004 Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He is the editor of the new book, Coincidence or Crisis, a discussion of global prescription medicine counterfeiting. In this podcast, we discuss the potential impact of the International Pricing Index (IPI) on global innovation, as well as several alternatives which could be put in place that would create less havoc for innovators and patients. As well, we discuss the increasing divergence of the innovative capacity between the US and Europe, and how the current systems of reimbursement are impacting the ability to support and R&D ecosystem.
How much do you pay for your meds? Given the skyrocketing price of pharmaceutical drugs, probably way too much. So how do we solve that problem? Rick talks with Peter Pitts, former FDA Associate Commissioner and President and co-founder of the Center for Medicine in the Public Interest.
Tuesday's edition of Trending Today USA was hosted by Liftable Media's Ernie Brown.In this half hour, the guests and topics discussed were:1. The Top 5 Trending Stories2. Michael Reagan (son of Ronald Reagan) -- White House leaker charged3. Hal Nunn (Liftable Media) -- Amazon to offer Prime membership at a discount for those receiving federal assistance.4. Peter Pitts (president, Center for Medicine in the Public Interest) -- More and more states are declaring the opiod crisis a public-health emergency.Like us on Facebook!Image credit: Timofeev Sergey / Shutterstock.com
Countdown to Election Day! Today's topic is HEALTHCARE John speaks to Peter Pitts from The Center For Medicine In The Public Interest. LEARN MORE AT - http://cmpi.org/
Countdown to Election Day!Today's topic is HEALTHCAREJohn speaks to Peter Pitts from The Center For Medicine In The Public Interest.LEARN MORE AT - http://cmpi.org/
Sep 12th - Football, What We Ate, Presidential Succession, Peter Pitts, Rob Waters, Tommy Davidson
Sep 12th - Football, What We Ate, Presidential Succession, Peter Pitts, Rob Waters, Tommy Davidson
Dr. Drew and Mike Catherwood talk with Peter Pitts about President Obama's speech on Drug addiction.
Last month, the Senate confirmed Robert Califf, a cardiologist and clinical researcher from Duke University, as commissioner of the U.S. Food and Drug Administration. Though he was overwhelming confirmed, some expressed concerns about his ties to the pharmaceutical industry. Others used the confirmation process to protest the FDA's handling of opioid painkillers as the problem of addiction to these drugs have become a growing concern. We spoke to Peter Pitts, a former FDA associate commissioner and president of the Center for Medicine in the Public Interest, about Califf, why he's well suited for the job, and the challenges he will face in his new role.
Guest: Peter Pitts Host: Larry Kaskel, MD Healthcare reform! The buzz word of candidates and policy makers, healthcare managers, doctors, and patients. What are the underlying problems in our healthcare system and what should we do? Join host Dr. Larry Kaskel interview our guest Peter Pitts.
Guest: Peter Pitts Host: Larry Kaskel, MD Many are eagerly awaiting approval of certain drugs whether it be to cure a patient or to realize the research put into the development of the drug. Would a speedier drug approval process ultimately help or hinder our healthcare system? Join Dr. Larry Kaskel interviewing Peter Pitts, co-founder of the Center for Medicine in the Public Interest.